126 related articles for article (PubMed ID: 8096762)
1. Pediatric osteosarcoma: treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP)--advantages, disadvantages, and controversial issues.
Jaffe N
Cancer Treat Res; 1993; 62():75-84. PubMed ID: 8096762
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma.
Jaffe N; Robertson R; Ayala A; Wallace S; Chuang V; Anzai T; Cangir A; Wang YM; Chen T
J Clin Oncol; 1985 Aug; 3(8):1101-4. PubMed ID: 3874932
[TBL] [Abstract][Full Text] [Related]
3. Intraarterial chemotherapy for osteosarcoma: does the result really justify the effort?
Bielack SS; Bieling P; Erttmann R; Winkler K
Cancer Treat Res; 1993; 62():85-92. PubMed ID: 8096763
[TBL] [Abstract][Full Text] [Related]
4. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
[TBL] [Abstract][Full Text] [Related]
5. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
[TBL] [Abstract][Full Text] [Related]
6. Pediatric osteosarcoma. Successful retreatment of relapsed primary tumor and soft tissue recurrence with intraarterial cis-diamminedichloroplatin-II.
Epelman S; Estrada J; Jaffe N; Bianchi A
Cancer; 1990 Aug; 66(4):801-5. PubMed ID: 2386906
[TBL] [Abstract][Full Text] [Related]
7. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
[TBL] [Abstract][Full Text] [Related]
8. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors.
Picci P; Bacci G; Ferrari S; Mercuri M
Ann Oncol; 1997 Nov; 8(11):1107-15. PubMed ID: 9426330
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide tolerance in osteosarcoma patients previously treated with cis-diamminedichloroplatinum-II: renal, hematologic, and neurologic observations.
Canpolat C; Pearson P; Robertson R; Jaffe N
Med Pediatr Oncol; 1996 Jan; 26(1):36-47. PubMed ID: 7494510
[TBL] [Abstract][Full Text] [Related]
11. Effect of chemotherapy combined with caffeine for osteosarcoma.
Tsuchiya H; Yasutake H; Yokogawa A; Baba H; Ueda Y; Tomita K
J Cancer Res Clin Oncol; 1992; 118(8):567-9. PubMed ID: 1517277
[TBL] [Abstract][Full Text] [Related]
12. Control of primary osteosarcoma with chemotherapy.
Jaffe N; Robertson R; Takaue Y; Cangir A; Wallace S; Carrasco H; Eftekhari F; Ayala A; Wang A
Cancer; 1985 Aug; 56(3):461-6. PubMed ID: 3873985
[TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
[TBL] [Abstract][Full Text] [Related]
14. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86).
Winkler K; Bielack S; Delling G; Salzer-Kuntschik M; Kotz R; Greenshaw C; Jürgens H; Ritter J; Kusnierz-Glaz C; Erttmann R
Cancer; 1990 Oct; 66(8):1703-10. PubMed ID: 2208024
[TBL] [Abstract][Full Text] [Related]
15. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
[TBL] [Abstract][Full Text] [Related]
17. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
[TBL] [Abstract][Full Text] [Related]
18. Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.
Cassano WF; Graham-Pole J; Dickson N
Cancer; 1991 Nov; 68(9):1899-902. PubMed ID: 1913541
[TBL] [Abstract][Full Text] [Related]
19. Effect of cumulative courses of intraarterial cis-diamminedichloroplatin-II on the primary tumor in osteosarcoma.
Jaffe N; Raymond AK; Ayala A; Carrasco CH; Wallace S; Robertson R; Griffiths M; Wang YM
Cancer; 1989 Jan; 63(1):63-7. PubMed ID: 2910425
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic isolated perfusion using cisplatin for treatment of the extremities.
Takeyama S; Tateishi A; Higaki S; Yamanashi M
Cancer Treat Res; 1993; 62():235-40. PubMed ID: 8096738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
